세계의 원격 모니터링 시스템 시장

Global Telemonitoring Systems Market to Reach US$4.5 Billion by 2030

The global market for Telemonitoring Systems estimated at US$2.7 Billion in the year 2024, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 8.6% over the analysis period 2024-2030. COPD Monitoring, one of the segments analyzed in the report, is expected to record a 8.1% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Blood Pressure Monitoring segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$705.3 Million While China is Forecast to Grow at 11.4% CAGR

The Telemonitoring Systems market in the U.S. is estimated at US$705.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$986.7 Million by the year 2030 trailing a CAGR of 11.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.7% and 6.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Global Telemonitoring Systems Market - Key Trends and Drivers Summarized

What Are Telemonitoring Systems and Why Are They Critical in Healthcare?

Telemonitoring systems enable healthcare providers to remotely monitor patients’ vital signs, symptoms, and overall health conditions using digital communication technologies. These systems are essential for chronic disease management, post-acute care, and elderly care, providing continuous monitoring without the need for frequent hospital visits. By transmitting real-time data such as blood pressure, heart rate, glucose levels, and oxygen saturation, telemonitoring systems allow healthcare professionals to make timely interventions, adjust treatment plans, and improve patient outcomes. This is particularly vital in the context of an aging population and increasing incidences of chronic diseases such as diabetes and cardiovascular conditions, where proactive monitoring is key to reducing hospitalizations and managing healthcare costs.

How Are Telemonitoring Systems Being Used Across Healthcare Settings?

Telemonitoring systems are widely used in hospitals, clinics, and home healthcare settings, providing flexibility for both patients and providers. In hospital settings, telemonitoring is integrated into broader telehealth strategies, allowing clinicians to track the recovery of patients post-surgery or during treatment for chronic conditions. In home healthcare, telemonitoring empowers patients to self-manage their health, while doctors and nurses can access patient data remotely to make informed decisions. This is particularly beneficial in rural areas where access to healthcare facilities is limited. Additionally, telemonitoring systems are employed in specialized care, such as remote monitoring for patients undergoing rehabilitation, as well as for maternity and pediatric care to ensure continuous oversight without frequent hospital visits.

What Are the Key Segments in the Telemonitoring Systems Market?

Key components include devices (such as sensors, wearables, and mobile health apps) and services (such as data collection, analytics, and real-time reporting). Applications span chronic disease management, post-acute care, preventive care, and elderly care. In terms of end-use, hospitals, home care settings, and clinics form the primary market segments. Regionally, North America leads the market due to advanced healthcare infrastructure, while Asia-Pacific is witnessing rapid growth driven by increasing adoption of telehealth technologies and government initiatives to improve healthcare access in remote areas. Emerging markets are also contributing to growth as healthcare providers embrace telemonitoring to address infrastructure challenges.

The Growth in the Telemonitoring Systems Market Is Driven by Several Factors

The growth in the telemonitoring systems market is driven by several factors, including the rising prevalence of chronic diseases, the growing elderly population, and advancements in wearable and wireless technologies. The increasing focus on home healthcare solutions, which allow patients to manage their conditions from home, is significantly boosting the demand for telemonitoring systems. Additionally, regulatory support for telehealth and reimbursement policies in regions like North America and Europe are fueling market expansion. The integration of AI and machine learning into telemonitoring systems is further enhancing predictive analytics capabilities, enabling more proactive care. The rapid adoption of 5G technology, which facilitates real-time data transmission with minimal latency, is also expected to accelerate market growth.

SCOPE OF STUDY:

The report analyzes the Telemonitoring Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 26 Featured) -

• Abbott Laboratories
• Aerotel Medical Systems (19) Ltd.
• Allscripts Healthcare Solutions, Inc.
• BioTelemetry, Inc.
• Biotronik SE & Co. KG
• Dragerwerk AG & Co. KGaA
• Dream Systems LLC.
• eVisit, Inc.
• General Electric Company
• Honeywell Life Care Solutions
• Huawei Technologies Co., Ltd.
• InTouch Health
• LifeWatch AG
• McKesson Corporation
• Medtronic, Inc.
• Philips Healthcare USA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Telemonitoring Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increasing Prevalence of Chronic Diseases Drives Adoption of Telemonitoring Systems
  • Rising Demand for Remote Patient Monitoring Strengthens Business Case for Telemonitoring
  • Growth of the Elderly Population Spurs Demand for Telemonitoring Solutions
  • Advancements in Wireless and Wearable Technologies Propel Growth in Telemonitoring
  • Expanding Use of Telemonitoring in Post-Acute Care Accelerates Market Expansion
  • Rising Healthcare Costs Drive Adoption of Cost-Effective Remote Monitoring Systems
  • Integration of AI and Machine Learning in Telemonitoring Systems Enhances Market Growth
  • Increased Focus on Home Healthcare Solutions Spurs Demand for Telemonitoring
  • Growing Use of Telemonitoring for Managing Diabetes and Cardiovascular Diseases Propels Market
  • Shift Toward Value-Based Care Strengthens Demand for Remote Monitoring Solutions
  • Emergence of 5G Technology Accelerates Adoption of Real-Time Telemonitoring
  • COVID-19 Pandemic Throws the Spotlight on Remote Monitoring and Telehealth Solutions
  • Rising Demand for Real-Time Data Analytics and Predictive Insights in Healthcare Sustains Growth
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Telemonitoring Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Telemonitoring Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for COPD Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for COPD Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Blood Pressure Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Blood Pressure Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Glucose Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Glucose Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cardiovascular Disease Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cardiovascular Disease Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 20: USA Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 21: USA Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: USA 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 23: Canada Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 24: Canada Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: Canada 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 26: Japan Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 27: Japan Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: Japan 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 29: China Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 30: China Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: China 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: Europe Historic Review for Telemonitoring Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: Europe 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 35: Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: Europe 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 38: France Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: France Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: France 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 41: Germany Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Germany Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Germany 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 44: Italy Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Italy Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Italy 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 47: UK Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: UK Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: UK 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 50: Spain Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Spain Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Spain 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 53: Russia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Russia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Russia 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Rest of Europe Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Rest of Europe 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 60: Asia-Pacific Historic Review for Telemonitoring Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Asia-Pacific 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Asia-Pacific Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Asia-Pacific 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 65: Australia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Australia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Australia 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 68: India Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: India Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: India 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 71: South Korea Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: South Korea Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: South Korea 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 74: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Rest of Asia-Pacific Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Rest of Asia-Pacific 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 77: Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Latin America Historic Review for Telemonitoring Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Latin America 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 80: Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Latin America Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Latin America 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 83: Argentina Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Argentina Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Argentina 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 86: Brazil Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Brazil Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Brazil 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 89: Mexico Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Mexico Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Mexico 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 92: Rest of Latin America Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Rest of Latin America Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Rest of Latin America 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 95: Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 96: Middle East Historic Review for Telemonitoring Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Middle East 15-Year Perspective for Telemonitoring Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 98: Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Middle East Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Middle East 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 101: Iran Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Iran Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Iran 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 104: Israel Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Israel Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Israel 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 107: Saudi Arabia Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Saudi Arabia Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Saudi Arabia 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 110: UAE Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UAE Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UAE 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 113: Rest of Middle East Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Middle East Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Middle East 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Telemonitoring Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 116: Africa Recent Past, Current & Future Analysis for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Africa Historic Review for Telemonitoring Systems by End-Use - COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Africa 15-Year Perspective for Telemonitoring Systems by End-Use - Percentage Breakdown of Value Sales for COPD Monitoring, Blood Pressure Monitoring, Glucose Monitoring, Cardiovascular Disease Monitoring and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION